Urological Association, Chinese Research Hospital Association (CRHA) , Urological Health Promotive Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM) , Evidence-Based Medicine Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM) , The Project Team for Minimally Invasive Plasmakinetic System and Cloud Planning Solution, The National Key Research and Development Program of China
The Project Team for Minimally Invasive Plasmakinetic System and Cloud Planning Solution, The National Key Research and Development Program of China, Email:
Benign prostatic hyperplasia; Transurethral bipolar plasmakinetic prostatectomy; Clinical practice guideline
10.7507/1672-2531.201804068
Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables References Cited by

Citation： Urological Association, Chinese Research Hospital Association (CRHA), Urological Health Promotive Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM), Evidence-Based Medicine Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM), The Project Team for Minimally Invasive Plasmakinetic System and Cloud Planning Solution, The National Key Research and Development Program of China. Transurethral bipolar plasmakinetic prostatectomy treatment for benign prostatic hyperplasia in Chinese: development of a national evidence-based clinical practice guideline (2018 simplified version). Chinese Journal of Evidence-Based Medicine, 2018, 18(6): 543-546. doi: 10.7507/1672-2531.201804068 Copy

  • Previous Article

    Transparency and sharing individual participant data of clinical trials: a philosophical proposition about the medical study ethics and implications for clinical trials

  • Next Article

    China expert consensus on home nutrition administration for elderly patients with dysphagia (version 2018)